{"id":1727,"date":"2019-11-14T13:51:52","date_gmt":"2019-11-14T19:51:52","guid":{"rendered":"https:\/\/www.crpa-acrp-bulletin.ca\/?p=1727"},"modified":"2020-02-18T19:40:28","modified_gmt":"2020-02-19T01:40:28","slug":"webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin","status":"publish","type":"post","link":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/","title":{"rendered":"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1728 size-full\" src=\"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/CRPA-40-4-Gaw_POST.jpg\" alt=\"\" width=\"1200\" height=\"963\" srcset=\"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/CRPA-40-4-Gaw_POST.jpg 1200w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/CRPA-40-4-Gaw_POST-300x241.jpg 300w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/CRPA-40-4-Gaw_POST-768x616.jpg 768w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/CRPA-40-4-Gaw_POST-1024x822.jpg 1024w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/CRPA-40-4-Gaw_POST-520x417.jpg 520w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/p>\n<div class='content-column one_third'><div style=\"padding-right:10px;\"><div style=\"padding: 8px 5px 5px 5px; background-color: #eeeeee; border: #dddddd 2px solid;\">\n<h4>R\u00e9sum\u00e9<\/h4>\n<p>Depuis les modifications de 2011 apport\u00e9es aux limites de dose pour le cristallin et recommand\u00e9es par la Commission internationale de protection radiologique (CIPR), la science sous-jacente aux modifications, les d\u00e9fis de l\u2019implantation associ\u00e9s aux limites de dose inf\u00e9rieure et la dosim\u00e9trie du cristallin ont nourri bien des discussions et g\u00e9n\u00e9r\u00e9 beaucoup d\u2019int\u00e9r\u00eat.\u00a0Pour \u00e9tudier ces questions, l\u2019Association canadienne de la radioprotection et la Commission canadienne de s\u00fbret\u00e9 nucl\u00e9aire ont rassembl\u00e9 des conf\u00e9renciers experts de partout dans le monde pour cr\u00e9er une s\u00e9rie de webinaires en 2018.<\/p>\n<\/div><\/div><\/div>\n<div class='content-column two_third last_column'><div style=\"padding-left:10px;\"><p>Following changes in 2011 to the International Commission on Radiological Protection (ICRP) recommended dose limits for the lens of the eye, there has been much interest and discussion regarding the science supporting the change, implementation challenges associated with the lower dose limits, and dosimetry for the lens of the eye.<\/p>\n<p>To explore these issues, the Canadian Radiation Protection Association (CRPA) and the Canadian Nuclear Safety Commission (CNSC) co-hosted a webinar series on dose limits for the lens of the eye. The three webinars brought together expert speakers from around the world to discuss the following topics:<\/p>\n<ul>\n<li>Scientific basis for ICRP\u2019s recommended dose limits for the lens of the eye (March 21, 2018)<\/li>\n<li>Implementation of ICRP\u2019s dose limits for the lens of the eye (September 27, 2018)<\/li>\n<li>Dosimeters for the lens of the eye (June 6, 2019)<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong>Radiation protection professionals from around the globe viewed the webinars. Some took advantage of this opportunity to pose questions to the expert speakers. It was clear from the level of interest and the feedback we received that radiation protection professionals are taking measures to assess and optimize doses to the lens of the eye.<\/p>\n<p>To view the presentations and webinar recordings, visit one of the following websites:<\/p>\n<ul>\n<li>CRPA \u2013 <a href=\"https:\/\/crpa-acrp.org\/home\/?page_id=11845\" target=\"_blank\" rel=\"noopener noreferrer\">Recorded Webinars &amp; Presentations<\/a><\/li>\n<li>CNSC \u2013 <a href=\"http:\/\/nuclearsafety.gc.ca\/eng\/acts-and-regulations\/consultation\/history\/dis-13-01-webinar.cfm?pedisable=true\" target=\"_blank\" rel=\"noopener noreferrer\">Webinars on lens of the eye<\/a><\/li>\n<\/ul>\n<div style=\"padding: 10px 10px 0 10px; background-color: #eeeeee; border: #dddddd 2px solid;\">\n<h2><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-1328\" src=\"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2018\/12\/adelene-300x300.jpg\" alt=\"\" width=\"125\" height=\"125\" srcset=\"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2018\/12\/adelene-300x300.jpg 300w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2018\/12\/adelene-150x150.jpg 150w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2018\/12\/adelene-160x160.jpg 160w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2018\/12\/adelene-320x320.jpg 320w, https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2018\/12\/adelene.jpg 518w\" sizes=\"auto, (max-width: 125px) 100vw, 125px\" \/><strong>Adelene Gaw<\/strong><\/h2>\n<p>Adelene Gaw is working in the Radon Technical Operations Section at Health Canada\u2019s Radiation Protection Bureau. Before this, she worked in the Radiation Protection Division at the Canadian Nuclear Safety Commission.<\/p>\n<p>Adelene Gaw travaille \u00e0 la Section des op\u00e9rations techniques du radon, au Bureau de la radioprotection de Sant\u00e9 Canada. Auparavant, elle a travaill\u00e9 \u00e0 la Division de la radioprotection, \u00e0 la Commission canadienne de s\u00fbret\u00e9 nucl\u00e9aire.<\/p>\n<\/div><\/div><\/div><div class='clear_column'><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Following changes in 2011 to the ICRP recommended dose limits for the lens of the eye, there has been much interest and discussion regarding the science supporting the change, implementation challenges associated with the lower dose limits, and dosimetry for the lens of the eye. \/ Depuis les modifications de 2011 apport\u00e9es aux limites de dose pour le cristallin et recommand\u00e9es par la CIPR, la science sous-jacente aux modifications, les d\u00e9fis de l\u2019implantation associ\u00e9s aux limites de dose inf\u00e9rieure et la dosim\u00e9trie du cristallin ont nourri bien des discussions et g\u00e9n\u00e9r\u00e9 beaucoup d\u2019int\u00e9r\u00eat.<\/p>\n","protected":false},"author":49,"featured_media":1729,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[3,2],"tags":[],"class_list":["post-1727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-features"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin - CRPA-ACRP Bulletin<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin - CRPA-ACRP Bulletin\" \/>\n<meta property=\"og:description\" content=\"Following changes in 2011 to the ICRP recommended dose limits for the lens of the eye, there has been much interest and discussion regarding the science supporting the change, implementation challenges associated with the lower dose limits, and dosimetry for the lens of the eye. \/ Depuis les modifications de 2011 apport\u00e9es aux limites de dose pour le cristallin et recommand\u00e9es par la CIPR, la science sous-jacente aux modifications, les d\u00e9fis de l\u2019implantation associ\u00e9s aux limites de dose inf\u00e9rieure et la dosim\u00e9trie du cristallin ont nourri bien des discussions et g\u00e9n\u00e9r\u00e9 beaucoup d\u2019int\u00e9r\u00eat.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/\" \/>\n<meta property=\"og:site_name\" content=\"CRPA-ACRP Bulletin\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-14T19:51:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-02-19T01:40:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/GAW_FTR.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Adelene Gaw, Radiation Protection Bureau, Health Canada\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Adelene Gaw, Radiation Protection Bureau, Health Canada\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/\"},\"author\":{\"name\":\"Adelene Gaw, Radiation Protection Bureau, Health Canada\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#\\\/schema\\\/person\\\/5bade052021103241980d9b8a2128380\"},\"headline\":\"Webinar Series: Dose Limits for the Lens of the Eye \\\/ S\u00e9rie de webinaires : Limites de dose pour le cristallin\",\"datePublished\":\"2019-11-14T19:51:52+00:00\",\"dateModified\":\"2020-02-19T01:40:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/\"},\"wordCount\":418,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/GAW_FTR.jpg\",\"articleSection\":[\"Articles\",\"Features\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/\",\"url\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/\",\"name\":\"Webinar Series: Dose Limits for the Lens of the Eye \\\/ S\u00e9rie de webinaires : Limites de dose pour le cristallin - CRPA-ACRP Bulletin\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/GAW_FTR.jpg\",\"datePublished\":\"2019-11-14T19:51:52+00:00\",\"dateModified\":\"2020-02-19T01:40:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/GAW_FTR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/GAW_FTR.jpg\",\"width\":600,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/2019\\\/11\\\/14\\\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Webinar Series: Dose Limits for the Lens of the Eye \\\/ S\u00e9rie de webinaires : Limites de dose pour le cristallin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/\",\"name\":\"CRPA-ACRP Bulletin\",\"description\":\"Canadian Radiation Protection Association \\\/ Association canadienne de radioprotection\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#organization\",\"name\":\"Canadian Radiation Protection Association Association \u2013 Canadienne de Radioprotection\",\"url\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/cropped-Site-icon-50-80-119.png\",\"contentUrl\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/cropped-Site-icon-50-80-119.png\",\"width\":512,\"height\":512,\"caption\":\"Canadian Radiation Protection Association Association \u2013 Canadienne de Radioprotection\"},\"image\":{\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/#\\\/schema\\\/person\\\/5bade052021103241980d9b8a2128380\",\"name\":\"Adelene Gaw, Radiation Protection Bureau, Health Canada\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f71e0c474199aaef23ce3011fbdaf0b8d71198e9eda16da7b5490ef83749d0c0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f71e0c474199aaef23ce3011fbdaf0b8d71198e9eda16da7b5490ef83749d0c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f71e0c474199aaef23ce3011fbdaf0b8d71198e9eda16da7b5490ef83749d0c0?s=96&d=mm&r=g\",\"caption\":\"Adelene Gaw, Radiation Protection Bureau, Health Canada\"},\"url\":\"https:\\\/\\\/www.crpa-acrp-bulletin.ca\\\/fr\\\/author\\\/adelenegawhc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin - CRPA-ACRP Bulletin","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/","og_locale":"fr_FR","og_type":"article","og_title":"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin - CRPA-ACRP Bulletin","og_description":"Following changes in 2011 to the ICRP recommended dose limits for the lens of the eye, there has been much interest and discussion regarding the science supporting the change, implementation challenges associated with the lower dose limits, and dosimetry for the lens of the eye. \/ Depuis les modifications de 2011 apport\u00e9es aux limites de dose pour le cristallin et recommand\u00e9es par la CIPR, la science sous-jacente aux modifications, les d\u00e9fis de l\u2019implantation associ\u00e9s aux limites de dose inf\u00e9rieure et la dosim\u00e9trie du cristallin ont nourri bien des discussions et g\u00e9n\u00e9r\u00e9 beaucoup d\u2019int\u00e9r\u00eat.","og_url":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/","og_site_name":"CRPA-ACRP Bulletin","article_published_time":"2019-11-14T19:51:52+00:00","article_modified_time":"2020-02-19T01:40:28+00:00","og_image":[{"width":600,"height":300,"url":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/GAW_FTR.jpg","type":"image\/jpeg"}],"author":"Adelene Gaw, Radiation Protection Bureau, Health Canada","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Adelene Gaw, Radiation Protection Bureau, Health Canada","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#article","isPartOf":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/"},"author":{"name":"Adelene Gaw, Radiation Protection Bureau, Health Canada","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#\/schema\/person\/5bade052021103241980d9b8a2128380"},"headline":"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin","datePublished":"2019-11-14T19:51:52+00:00","dateModified":"2020-02-19T01:40:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/"},"wordCount":418,"commentCount":0,"publisher":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#organization"},"image":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#primaryimage"},"thumbnailUrl":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/GAW_FTR.jpg","articleSection":["Articles","Features"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/","url":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/","name":"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin - CRPA-ACRP Bulletin","isPartOf":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#primaryimage"},"image":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#primaryimage"},"thumbnailUrl":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/GAW_FTR.jpg","datePublished":"2019-11-14T19:51:52+00:00","dateModified":"2020-02-19T01:40:28+00:00","breadcrumb":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#primaryimage","url":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/GAW_FTR.jpg","contentUrl":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2019\/11\/GAW_FTR.jpg","width":600,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/2019\/11\/14\/webinar-series-dose-limits-for-the-lens-of-the-eye-serie-de-webinaires-limites-de-dose-pour-le-cristallin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.crpa-acrp-bulletin.ca\/"},{"@type":"ListItem","position":2,"name":"Webinar Series: Dose Limits for the Lens of the Eye \/ S\u00e9rie de webinaires : Limites de dose pour le cristallin"}]},{"@type":"WebSite","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#website","url":"https:\/\/www.crpa-acrp-bulletin.ca\/","name":"CRPA-ACRP Bulletin","description":"Canadian Radiation Protection Association \/ Association canadienne de radioprotection","publisher":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.crpa-acrp-bulletin.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#organization","name":"Canadian Radiation Protection Association Association \u2013 Canadienne de Radioprotection","url":"https:\/\/www.crpa-acrp-bulletin.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2017\/11\/cropped-Site-icon-50-80-119.png","contentUrl":"https:\/\/www.crpa-acrp-bulletin.ca\/wp-content\/uploads\/2017\/11\/cropped-Site-icon-50-80-119.png","width":512,"height":512,"caption":"Canadian Radiation Protection Association Association \u2013 Canadienne de Radioprotection"},"image":{"@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.crpa-acrp-bulletin.ca\/#\/schema\/person\/5bade052021103241980d9b8a2128380","name":"Adelene Gaw, Radiation Protection Bureau, Health Canada","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/f71e0c474199aaef23ce3011fbdaf0b8d71198e9eda16da7b5490ef83749d0c0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f71e0c474199aaef23ce3011fbdaf0b8d71198e9eda16da7b5490ef83749d0c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f71e0c474199aaef23ce3011fbdaf0b8d71198e9eda16da7b5490ef83749d0c0?s=96&d=mm&r=g","caption":"Adelene Gaw, Radiation Protection Bureau, Health Canada"},"url":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/author\/adelenegawhc\/"}]}},"_links":{"self":[{"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/posts\/1727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/comments?post=1727"}],"version-history":[{"count":0,"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/posts\/1727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/media\/1729"}],"wp:attachment":[{"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/media?parent=1727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/categories?post=1727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.crpa-acrp-bulletin.ca\/fr\/wp-json\/wp\/v2\/tags?post=1727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}